Literature DB >> 20450414

Geoclimatic influences on invasive aspergillosis after hematopoietic stem cell transplantation.

Anil A Panackal1, Hong Li, Dimitrios P Kontoyiannis, Motomi Mori, Cheryl A Perego, Michael Boeckh, Kieren A Marr.   

Abstract

BACKGROUND: Aspergillus species are ubiquitous. We hypothesized that climatic variables that affect airborne mold counts affect the incidence of invasive aspergillosis (IA).
METHODS: Patients who received hematopoietic stem cell transplants (HSCTs) in geographically and climatically diverse regions (Seattle, WA, and Houston, TX) were examined. Cumulative incidence function, Kaplan-Meier analysis, and Cox proportional hazards regression were performed to examine the association between IA and season. Poisson regression analysis was performed to evaluate the seasonal patterns in IA rates and association with spore counts and climate.
RESULTS: In Seattle, the 3-month incidence of IA was 4.6% (5.7% in allograft recipients and 0.8% in autograft recipients). During the 10-year study period, there was a decrease in the incidence of IA among allogeneic HSCT recipients, corresponding to decreased risks during the nonsummer months; receipt of HSCTs during the summer months was associated with an increased hazard for IA (hazard ratio, 1.87; 95% confidence interval, 1.25-2.81) after adjustment for other known risks. The person-month IA rate in Seattle was positively associated with environmental spore counts, which increased with high temperature and low precipitation. No seasonal effect on IA was observed in Houston, where total spore counts were lower and not variable by climate.
CONCLUSIONS: Climatic variables differentially affect airborne spore counts and IA risk in geographically disparate centers.

Entities:  

Mesh:

Year:  2010        PMID: 20450414      PMCID: PMC3024009          DOI: 10.1086/652761

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  27 in total

Review 1.  Seasonality and photoperiodism in fungi.

Authors:  T Roenneberg; M Merrow
Journal:  J Biol Rhythms       Date:  2001-08       Impact factor: 3.182

2.  Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients.

Authors:  Kieren A Marr; Rachel A Carter; Fulvio Crippa; Anna Wald; Lawrence Corey
Journal:  Clin Infect Dis       Date:  2002-02-26       Impact factor: 9.079

3.  Late onset of invasive aspergillus infection in bone marrow transplant patients at a university hospital.

Authors:  W B Grow; J S Moreb; D Roque; K Manion; H Leather; V Reddy; S A Khan; K J Finiewicz; H Nguyen; C J Clancy; P S Mehta; J R Wingard
Journal:  Bone Marrow Transplant       Date:  2002-01       Impact factor: 5.483

4.  Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

Authors:  S Ascioglu; J H Rex; B de Pauw; J E Bennett; J Bille; F Crokaert; D W Denning; J P Donnelly; J E Edwards; Z Erjavec; D Fiere; O Lortholary; J Maertens; J F Meis; T F Patterson; J Ritter; D Selleslag; P M Shah; D A Stevens; T J Walsh
Journal:  Clin Infect Dis       Date:  2001-11-26       Impact factor: 9.079

5.  Hospital-acquired Aspergillus fumigatus infection: can molecular typing methods identify an environmental source?

Authors:  F Symoens; J Burnod; B Lebeau; M A Viviani; M A Piens; A M Tortorano; N Nolard; F Chapuis; R Grillot
Journal:  J Hosp Infect       Date:  2002-09       Impact factor: 3.926

6.  Indoor viable mold spores--a comparison between two cities, Erfurt (eastern Germany) and Hamburg (western Germany).

Authors:  A Koch; K J Heilemann; W Bischof; J Heinrich; H E Wichmann
Journal:  Allergy       Date:  2000-02       Impact factor: 13.146

7.  Evaluation of performance of four genotypic methods for studying the genetic epidemiology of Aspergillus fumigatus isolates.

Authors:  Brent A Lasker
Journal:  J Clin Microbiol       Date:  2002-08       Impact factor: 5.948

8.  Efficacy of high-efficiency particulate air filtration in preventing aspergillosis in immunocompromised patients with hematologic malignancies.

Authors:  Theresa Hahn; K Michael Cummings; Arthur M Michalek; Brian J Lipman; Brahm H Segal; Philip L McCarthy
Journal:  Infect Control Hosp Epidemiol       Date:  2002-09       Impact factor: 3.254

9.  Molecular evidence that the range of the Vancouver Island outbreak of Cryptococcus gattii infection has expanded into the Pacific Northwest in the United States.

Authors:  Edmond J Byrnes; Robert J Bildfell; Sheryl A Frank; Thomas G Mitchell; Kieren A Marr; Joseph Heitman
Journal:  J Infect Dis       Date:  2009-04-01       Impact factor: 5.226

10.  Seasonal variation in host susceptibility and cycles of certain infectious diseases.

Authors:  S F Dowell
Journal:  Emerg Infect Dis       Date:  2001 May-Jun       Impact factor: 6.883

View more
  23 in total

Review 1.  Primary antifungal prophylaxis during curative-intent therapy for acute myeloid leukemia.

Authors:  Anna B Halpern; Gary H Lyman; Thomas J Walsh; Dimitrios P Kontoyiannis; Roland B Walter
Journal:  Blood       Date:  2015-10-26       Impact factor: 22.113

2.  Epidemiology, outcomes, and mortality predictors of invasive mold infections among transplant recipients: a 10-year, single-center experience.

Authors:  D Neofytos; S Treadway; D Ostrander; C D Alonso; K L Dierberg; V Nussenblatt; C M Durand; C B Thompson; K A Marr
Journal:  Transpl Infect Dis       Date:  2013-02-21       Impact factor: 2.228

3.  Pre-chemotherapy risk factors for invasive fungal diseases: prospective analysis of 1,192 patients with newly diagnosed acute myeloid leukemia (SEIFEM 2010-a multicenter study).

Authors:  Morena Caira; Anna Candoni; Luisa Verga; Alessandro Busca; Mario Delia; Annamaria Nosari; Cecilia Caramatti; Carlo Castagnola; Chiara Cattaneo; Rosa Fanci; Anna Chierichini; Lorella Melillo; Maria Enza Mitra; Marco Picardi; Leonardo Potenza; Prassede Salutari; Nicola Vianelli; Luca Facchini; Monica Cesarini; Maria Rosaria De Paolis; Roberta Di Blasi; Francesca Farina; Adriano Venditti; Antonella Ferrari; Mariagrazia Garzia; Cristina Gasbarrino; Rosangela Invernizzi; Federica Lessi; Annunziata Manna; Bruno Martino; Gianpaolo Nadali; Massimo Offidani; Laura Paris; Vincenzo Pavone; Giuseppe Rossi; Antonio Spadea; Giorgina Specchia; Enrico Maria Trecarichi; Adriana Vacca; Simone Cesaro; Vincenzo Perriello; Franco Aversa; Mario Tumbarello; Livio Pagano
Journal:  Haematologica       Date:  2015-02       Impact factor: 9.941

Review 4.  Mucormycosis caused by unusual mucormycetes, non-Rhizopus, -Mucor, and -Lichtheimia species.

Authors:  Marisa Z R Gomes; Russell E Lewis; Dimitrios P Kontoyiannis
Journal:  Clin Microbiol Rev       Date:  2011-04       Impact factor: 26.132

5.  Future directions in mucormycosis research.

Authors:  Dimitrios P Kontoyiannis; Russell E Lewis; Oliver Lortholary; Oliver Lotholary; Brad Spellberg; Georgios Petrikkos; Emmanuel Roilides; Emmanuel Roillides; Ashraf Ibrahim; Thomas J Walsh
Journal:  Clin Infect Dis       Date:  2012-02       Impact factor: 9.079

6.  Atti Le giornate della ricerca scientificae delle esperienze professionali dei giovani: Società Italiana di Igiene, Medicina Preventiva e Sanità Pubblica (SItI) Roma 20-21 dicembre 2019.

Authors: 
Journal:  J Prev Med Hyg       Date:  2020-02-13

Review 7.  The ecology of pneumocystis: perspectives, personal recollections, and future research opportunities.

Authors:  Peter D Walzer
Journal:  J Eukaryot Microbiol       Date:  2013-09-03       Impact factor: 3.346

8.  Intracranial Aspergillosis in an Immunocompetent Young Woman.

Authors:  Prasan Kumar Panda; Sunil Kumar Mavidi; Naveet Wig; Ajay Garg; Aasma Nalwa; M C Sharma
Journal:  Mycopathologia       Date:  2017-01-04       Impact factor: 2.574

9.  Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.

Authors:  Thomas F Patterson; George R Thompson; David W Denning; Jay A Fishman; Susan Hadley; Raoul Herbrecht; Dimitrios P Kontoyiannis; Kieren A Marr; Vicki A Morrison; M Hong Nguyen; Brahm H Segal; William J Steinbach; David A Stevens; Thomas J Walsh; John R Wingard; Jo-Anne H Young; John E Bennett
Journal:  Clin Infect Dis       Date:  2016-06-29       Impact factor: 9.079

10.  Incidence of invasive aspergillosis following remission-induction chemotherapy for acute leukemia: a retrospective cohort study in a single Canadian tertiary care centre.

Authors:  Sapha Barkati; Simon F Dufresne; Sylvie Bélanger; Barbara Vadnais; Julie Bergeron; Annie Claude Labbé; Michel Laverdière
Journal:  CMAJ Open       Date:  2014-05-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.